Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antiepileptic medication interactions

I E Leppik1, D L Wolff

  • 1Department of Neurology, University of Minnesota, Minneapolis.

Neurologic Clinics
|November 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effect of topiramate plasma concentration on linguistic behavior, verbal recall and working memory.

Epilepsy & behavior : E&B·2012
Same author

Double-masked, placebo-controlled study of intravenous levetiracetam for the treatment of status epilepticus and acute repetitive seizures in dogs.

Journal of veterinary internal medicine·2012
Same author

Steady-state carbamazepine pharmacokinetics following oral and stable-labeled intravenous administration in epilepsy patients: effects of race and sex.

Clinical pharmacology and therapeutics·2012
Same author

Zonisamide discontinuation due to psychiatric and cognitive adverse events: a case-control study.

Neurology·2010
Same author

Phenytoin half-life and clearance during maintenance therapy in adults and elderly patients with epilepsy.

Neurology·2008
Same author

Intramuscular, intravenous and oral levetiracetam in dogs: safety and pharmacokinetics.

Journal of veterinary pharmacology and therapeutics·2008
Same journal

Sports Neurology.

Neurologic clinics·2026
Same journal

Sports-Related Peripheral Nerve Injuries.

Neurologic clinics·2026
Same journal

Active Rehabilitation and Return to Play in Sports-Related Concussion.

Neurologic clinics·2026
Same journal

Autonomic Assessment and Management in Sports-Related Concussion.

Neurologic clinics·2026
Same journal

Management of Vestibular Symptoms in Sports-Related Concussion.

Neurologic clinics·2026
Same journal

Neuropsychological Assessment in Sport-Related Concussion: Evidence, Controversies, and Clinical Applications.

Neurologic clinics·2026
See all related articles

Understanding antiepileptic drug (AED) interactions is crucial. Monitoring AED concentrations is vital, especially with polypharmacy, due to significant interpatient variability in drug interactions.

Area of Science:

  • Pharmacology
  • Clinical Pharmacy
  • Neurology

Background:

  • Antiepileptic drugs (AEDs) are frequently used in combination therapy.
  • Drug interactions involving AEDs can significantly alter their efficacy and safety profiles.
  • Understanding these interactions is critical for effective epilepsy management.

Purpose of the Study:

  • To highlight the importance of pharmacokinetic properties in AED interactions.
  • To emphasize the need for monitoring AED concentrations when multiple AEDs are used concurrently.
  • To discuss the implications of AED interactions for new drug development.

Main Methods:

  • Review of existing literature on antiepileptic drug interactions.
  • Analysis of pharmacokinetic principles governing AED metabolism and disposition.

Related Experiment Videos

  • Discussion of clinical implications based on observed drug concentration variations.

    • Main Results:

    • Generalizations about AED interactions are possible, but significant interpatient variability exists.
    • Measuring AED concentrations is recommended when initiating or discontinuing AEDs.
    • Both total and unbound AED concentrations may require monitoring in patients with refractory epilepsy or multiple seizure types.

    Conclusions:

    • Careful analysis of AED concentrations is essential, particularly in polypharmacy.
    • Early identification and understanding of interactions involving new AEDs are critical for their clinical success.
    • Individualized monitoring is key to optimizing AED therapy and preventing adverse outcomes.